SPRR4
gene geneOn this page
Summary
SPRR4 (small proline rich protein 4, HGNC:23173) is a protein-coding gene on chromosome 1q21.3, encoding Small proline-rich protein 4 (Q96PI1). Cross-linked envelope protein of keratinocytes.
Predicted to be involved in keratinization. Predicted to be located in cell cortex.
Source: NCBI Gene 163778 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 11 total
- MANE Select transcript:
NM_173080
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23173 |
| Approved symbol | SPRR4 |
| Name | small proline rich protein 4 |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000184148 |
| Ensembl biotype | protein_coding |
| OMIM | 616363 |
| Entrez | 163778 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000328051
RefSeq mRNA: 1 — MANE Select: NM_173080
NM_173080
CCDS: CCDS1031
Canonical transcript exons
ENST00000328051 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001293042 | 152970648 | 152970694 |
| ENSE00001309409 | 152971871 | 152972574 |
Expression profiles
Bgee: expression breadth broad, 90 present calls, max score 90.59.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.7442 / max 729.0675, expressed in 18 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 5332 | 0.7442 | 18 |
Top tissues by expression
204 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| upper leg skin | UBERON:0004262 | 90.59 | gold quality |
| sperm | CL:0000019 | 87.32 | gold quality |
| mammalian vulva | UBERON:0000997 | 84.27 | gold quality |
| skin of abdomen | UBERON:0001416 | 83.27 | gold quality |
| zone of skin | UBERON:0000014 | 82.54 | gold quality |
| skin of leg | UBERON:0001511 | 81.30 | gold quality |
| nipple | UBERON:0002030 | 80.32 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 77.17 | gold quality |
| cardia of stomach | UBERON:0001162 | 76.72 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 76.67 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 72.35 | gold quality |
| endothelial cell | CL:0000115 | 72.29 | silver quality |
| penis | UBERON:0000989 | 71.95 | gold quality |
| superior surface of tongue | UBERON:0007371 | 71.74 | silver quality |
| body of tongue | UBERON:0011876 | 71.31 | gold quality |
| vena cava | UBERON:0004087 | 71.22 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 71.15 | gold quality |
| trachea | UBERON:0003126 | 70.81 | silver quality |
| thymus | UBERON:0002370 | 70.68 | gold quality |
| pericardium | UBERON:0002407 | 70.58 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 70.41 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 70.40 | gold quality |
| pylorus | UBERON:0001166 | 70.31 | gold quality |
| renal medulla | UBERON:0000362 | 69.84 | gold quality |
| synovial joint | UBERON:0002217 | 69.84 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 69.78 | silver quality |
| pons | UBERON:0000988 | 69.61 | gold quality |
| right testis | UBERON:0004534 | 69.56 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 69.29 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 69.13 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.30 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
38 targeting SPRR4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-516A-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-516B-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-7162-5P | 99.46 | 68.08 | 1368 |
| HSA-MIR-4786-3P | 99.36 | 68.35 | 1390 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-4784 | 99.15 | 67.41 | 1733 |
| HSA-MIR-491-5P | 99.13 | 65.98 | 1468 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-6770-5P | 98.97 | 66.76 | 1853 |
| HSA-MIR-3150B-3P | 98.81 | 67.21 | 1728 |
| HSA-MIR-5197-3P | 98.71 | 67.05 | 1905 |
| HSA-MIR-3691-5P | 98.62 | 65.88 | 552 |
Literature-anchored findings (GeneRIF, showing 1)
- Association of psoriasis to PGLYRP and SPRR genes at PSORS4 locus on 1q shows heterogeneity between Finnish, Swedish and Irish families. (PMID:18643845)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Sprr4 | ENSMUSG00000045566 |
| rattus_norvegicus | Sprr4 | ENSRNOG00000042266 |
Paralogs (20): LCE2B (ENSG00000159455), SPRR2G (ENSG00000159516), LCE3D (ENSG00000163202), SPRR3 (ENSG00000163209), SPRR1B (ENSG00000169469), SPRR1A (ENSG00000169474), LCE1D (ENSG00000172155), LCE3A (ENSG00000185962), LCE3E (ENSG00000185966), LCE5A (ENSG00000186207), LCE1E (ENSG00000186226), LCE2A (ENSG00000187173), LCE2C (ENSG00000187180), LCE2D (ENSG00000187223), LCE3B (ENSG00000187238), KPLCE (ENSG00000198854), PRR9 (ENSG00000203783), LELP1 (ENSG00000203784), LCE1F (ENSG00000240386), LCE3C (ENSG00000244057)
Protein
Protein identifiers
Small proline-rich protein 4 — Q96PI1 (reviewed: Q96PI1)
All UniProt accessions (1): Q96PI1
UniProt curated annotations — full annotation on UniProt →
Function. Cross-linked envelope protein of keratinocytes. Involved in UV-induced cornification.
Subcellular location. Cytoplasm. Cell cortex.
Post-translational modifications. Cross-linked to membrane proteins by transglutaminase.
Induction. By UV irradiation.
Similarity. Belongs to the cornifin (SPRR) family.
RefSeq proteins (1): NP_775103* (*=MANE)
Domains & families (InterPro)
UniProt features (5 total): compositionally biased region 2, chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96PI1-F1 | 67.35 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 37 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN, GOBP_EPIDERMIS_DEVELOPMENT, GOBP_KERATINIZATION, GOBP_SKIN_DEVELOPMENT, chr1q21, MGGAAGTG_GABP_B, MARTENS_TRETINOIN_RESPONSE_UP, PEDRIOLI_MIR31_TARGETS_UP, GOBP_KERATINOCYTE_DIFFERENTIATION, GOBP_EPITHELIAL_CELL_DIFFERENTIATION, MIR1827, MIR765, MIR450A_1_3P
GO Biological Process (1): keratinization (GO:0031424)
GO Molecular Function (0):
GO Cellular Component (2): cell cortex (GO:0005938), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| keratinocyte differentiation | 1 |
| multicellular organismal process | 1 |
| cytoplasm | 1 |
| cell periphery | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
524 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPRR4 | LCE2A | Q5TA79 | 685 |
| SPRR4 | SPRR3 | Q9UBC9 | 668 |
| SPRR4 | LORICRIN | P23490 | 661 |
| SPRR4 | KPRP | Q5T749 | 646 |
| SPRR4 | IVL | P07476 | 627 |
| SPRR4 | TCHHL1 | Q5QJ38 | 626 |
| SPRR4 | LELP1 | Q5T871 | 604 |
| SPRR4 | LCE3A | Q5TA76 | 532 |
| SPRR4 | LCE3C | Q5T5A8 | 530 |
| SPRR4 | LCE1A | Q5T7P2 | 506 |
| SPRR4 | LCE6A | A0A183 | 505 |
| SPRR4 | KRTAP2-1 | Q9BYU5 | 500 |
| SPRR4 | SPRR2A | P35326 | 489 |
| SPRR4 | S100A2 | P29034 | 480 |
| SPRR4 | LCE3E | Q5T5B0 | 475 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EBAG9 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): SPRR4 (Affinity Capture-MS), SPRR4 (Protein-RNA), APP (Reconstituted Complex)
ESM2 similar proteins: A0A1B0GTR4, A6QNZ4, O14633, O70554, O70555, O70556, O70557, O70558, O70559, O70560, O70562, P15265, P22528, P22531, P22532, P35321, P35322, P35323, P35324, P35325, P35326, P49901, Q28658, Q32L04, Q4KL71, Q4R956, Q5T5B0, Q5T750, Q5T752, Q5T754, Q5T870, Q5T871, Q5TA76, Q5TA77, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q62266
Diamond homologs: Q8CGN8, Q96PI1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
11 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 11 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
136 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:152970692:CTGG:C | donor_loss | 0.9800 |
| 1:152970695:G:GA | donor_loss | 0.9800 |
| 1:152970696:T:TC | donor_loss | 0.9800 |
| 1:152971868:TAG:T | acceptor_loss | 0.9800 |
| 1:152971869:A:C | acceptor_loss | 0.9800 |
| 1:152971870:G:C | acceptor_loss | 0.9800 |
| 1:152970695:G:GG | donor_gain | 0.9700 |
| 1:152971869:A:AG | acceptor_gain | 0.9700 |
| 1:152971870:G:GG | acceptor_gain | 0.9700 |
| 1:152970699:G:GG | donor_gain | 0.9500 |
| 1:152971870:GGCT:G | acceptor_gain | 0.9500 |
| 1:152970698:A:AG | donor_gain | 0.9400 |
| 1:152971868:TAGG:T | acceptor_gain | 0.9400 |
| 1:152971870:GGCTC:G | acceptor_gain | 0.9400 |
| 1:152970692:CTG:C | donor_gain | 0.9100 |
| 1:152970697:AA:A | donor_loss | 0.9100 |
| 1:152971869:AG:A | acceptor_gain | 0.9100 |
| 1:152971870:GG:G | acceptor_gain | 0.9100 |
| 1:152970693:TG:T | donor_gain | 0.9000 |
| 1:152970694:GG:G | donor_gain | 0.9000 |
| 1:152971858:C:A | acceptor_gain | 0.9000 |
| 1:152970690:CTCTG:C | donor_gain | 0.8900 |
| 1:152971869:AGGC:A | acceptor_gain | 0.8900 |
| 1:152970803:G:T | donor_gain | 0.8800 |
| 1:152971867:TTAGG:T | acceptor_gain | 0.8600 |
| 1:152971870:GGC:G | acceptor_gain | 0.8600 |
| 1:152970691:TCTG:T | donor_gain | 0.8500 |
| 1:152971859:G:A | acceptor_gain | 0.8500 |
| 1:152971844:AT:A | acceptor_gain | 0.8300 |
| 1:152971281:GGTGC:G | donor_gain | 0.7700 |
AlphaMissense
514 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:152971962:G:C | K24N | 0.753 |
| 1:152971962:G:T | K24N | 0.753 |
| 1:152971969:T:C | C27R | 0.629 |
| 1:152971971:T:G | C27W | 0.614 |
dbSNP variants (sampled 300 via entrez): RS1000100779 (1:152969811 G>A), RS1000169827 (1:152968497 G>T), RS1001035156 (1:152968374 T>G), RS1002156968 (1:152971426 C>T), RS1002269984 (1:152970085 A>G), RS1002612161 (1:152971520 G>A), RS1002761406 (1:152970135 T>C), RS1003062278 (1:152971649 A>C), RS1003647839 (1:152967536 G>A,C), RS1004343148 (1:152972694 G>A), RS1004411744 (1:152966829 T>C), RS1004875813 (1:152968710 A>G), RS1005616780 (1:152971886 G>A,C), RS1005619248 (1:152967621 G>C), RS1005900172 (1:152972869 G>T)
Disease associations
OMIM: gene MIM:616363 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007564_25 | Asthma or allergic disease (pleiotropy) | 5.000000e-09 |
| GCST008916_87 | Asthma | 2.000000e-13 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation, affects methylation | 2 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Formaldehyde | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Sodium Dodecyl Sulfate | increases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.